Head-to-Head
Optavia vs Isagenix
Dead heat — these two are too close to call.
46
Momentum
43
#26
Rank
#30
0%
30-Day
+1%
-15%
90-Day
-14%
1
Streak (weeks)
1
Optavia — the case
"Fighting pharmaceuticals with shakes. Hard mode."
Growth
- • New maintenance plans
- • Coach-led model still works
Risk
- • Ozempic class is existential
- • Public stock cratered
Isagenix — the case
"Anti-Ozempic crowd is a real market now."
Growth
- • GLP-1 backlash sending people back to shakes
Risk
- • Aging rep force